Patient welfare and patient compliance: an empirical framework for measuring the benefits from pharmaceutical innovation
Gespeichert in:
| Beteiligte Personen: | , , |
|---|---|
| Format: | Buch |
| Sprache: | Englisch |
| Veröffentlicht: |
Cambridge, Mass.
1999
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
6890 |
| Schlagwörter: | |
| Links: | http://papers.nber.org/papers/w6890.pdf |
| Umfang: | 29 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012569794 | ||
| 003 | DE-604 | ||
| 005 | 19990526 | ||
| 007 | t| | ||
| 008 | 990520s1999 xxu |||| 00||| eng d | ||
| 035 | |a (OCoLC)40875744 | ||
| 035 | |a (DE-599)BVBBV012569794 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-473 |a DE-19 |a DE-521 | ||
| 050 | 0 | |a HB1 | |
| 084 | |a QB 910 |0 (DE-625)141231: |2 rvk | ||
| 100 | 1 | |a Ellickson, Paul |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Patient welfare and patient compliance |b an empirical framework for measuring the benefits from pharmaceutical innovation |c Paul Ellickson ; Scott Stern ; Manuel Trajtenberg |
| 264 | 1 | |a Cambridge, Mass. |c 1999 | |
| 300 | |a 29 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 6890 | |
| 650 | 4 | |a Ökonometrisches Modell | |
| 650 | 4 | |a Consumers' preferences |x Econometric models | |
| 650 | 4 | |a Drugs |x Prescribing |x Decision making |x Econometric models | |
| 650 | 4 | |a Drugs |x Technological innovations |x Econometric models | |
| 650 | 4 | |a Patient compliance |x Econometric models | |
| 650 | 4 | |a Physicians |x Attitudes |x Econometric models | |
| 700 | 1 | |a Stern, Scott |e Verfasser |4 aut | |
| 700 | 1 | |a Trajtenberg, Manuel |d 1950- |e Verfasser |0 (DE-588)129661686 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 6890 |w (DE-604)BV002801238 |9 6890 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w6890.pdf |z kostenfrei |3 Volltext |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-008535816 | |
Datensatz im Suchindex
| _version_ | 1818955093415821312 |
|---|---|
| any_adam_object | |
| author | Ellickson, Paul Stern, Scott Trajtenberg, Manuel 1950- |
| author_GND | (DE-588)129661686 |
| author_facet | Ellickson, Paul Stern, Scott Trajtenberg, Manuel 1950- |
| author_role | aut aut aut |
| author_sort | Ellickson, Paul |
| author_variant | p e pe s s ss m t mt |
| building | Verbundindex |
| bvnumber | BV012569794 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| classification_rvk | QB 910 |
| ctrlnum | (OCoLC)40875744 (DE-599)BVBBV012569794 |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01706nam a2200421 cb4500</leader><controlfield tag="001">BV012569794</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990526 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">990520s1999 xxu |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)40875744</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012569794</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-473</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-521</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QB 910</subfield><subfield code="0">(DE-625)141231:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ellickson, Paul</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patient welfare and patient compliance</subfield><subfield code="b">an empirical framework for measuring the benefits from pharmaceutical innovation</subfield><subfield code="c">Paul Ellickson ; Scott Stern ; Manuel Trajtenberg</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">29 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">6890</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ökonometrisches Modell</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Consumers' preferences</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prescribing</subfield><subfield code="x">Decision making</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Technological innovations</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patient compliance</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Physicians</subfield><subfield code="x">Attitudes</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stern, Scott</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Trajtenberg, Manuel</subfield><subfield code="d">1950-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129661686</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">6890</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">6890</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w6890.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008535816</subfield></datafield></record></collection> |
| id | DE-604.BV012569794 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T10:32:35Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008535816 |
| oclc_num | 40875744 |
| open_access_boolean | 1 |
| owner | DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-521 |
| owner_facet | DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-521 |
| physical | 29 S. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Ellickson, Paul Verfasser aut Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation Paul Ellickson ; Scott Stern ; Manuel Trajtenberg Cambridge, Mass. 1999 29 S. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 6890 Ökonometrisches Modell Consumers' preferences Econometric models Drugs Prescribing Decision making Econometric models Drugs Technological innovations Econometric models Patient compliance Econometric models Physicians Attitudes Econometric models Stern, Scott Verfasser aut Trajtenberg, Manuel 1950- Verfasser (DE-588)129661686 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 6890 (DE-604)BV002801238 6890 http://papers.nber.org/papers/w6890.pdf kostenfrei Volltext |
| spellingShingle | Ellickson, Paul Stern, Scott Trajtenberg, Manuel 1950- Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Ökonometrisches Modell Consumers' preferences Econometric models Drugs Prescribing Decision making Econometric models Drugs Technological innovations Econometric models Patient compliance Econometric models Physicians Attitudes Econometric models |
| title | Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation |
| title_auth | Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation |
| title_exact_search | Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation |
| title_full | Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation Paul Ellickson ; Scott Stern ; Manuel Trajtenberg |
| title_fullStr | Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation Paul Ellickson ; Scott Stern ; Manuel Trajtenberg |
| title_full_unstemmed | Patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation Paul Ellickson ; Scott Stern ; Manuel Trajtenberg |
| title_short | Patient welfare and patient compliance |
| title_sort | patient welfare and patient compliance an empirical framework for measuring the benefits from pharmaceutical innovation |
| title_sub | an empirical framework for measuring the benefits from pharmaceutical innovation |
| topic | Ökonometrisches Modell Consumers' preferences Econometric models Drugs Prescribing Decision making Econometric models Drugs Technological innovations Econometric models Patient compliance Econometric models Physicians Attitudes Econometric models |
| topic_facet | Ökonometrisches Modell Consumers' preferences Econometric models Drugs Prescribing Decision making Econometric models Drugs Technological innovations Econometric models Patient compliance Econometric models Physicians Attitudes Econometric models |
| url | http://papers.nber.org/papers/w6890.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT ellicksonpaul patientwelfareandpatientcomplianceanempiricalframeworkformeasuringthebenefitsfrompharmaceuticalinnovation AT sternscott patientwelfareandpatientcomplianceanempiricalframeworkformeasuringthebenefitsfrompharmaceuticalinnovation AT trajtenbergmanuel patientwelfareandpatientcomplianceanempiricalframeworkformeasuringthebenefitsfrompharmaceuticalinnovation |